Springe direkt zu Inhalt

Mara Wittig

mw

Department of infectious diseases and pulmonary medicine

Charité

Doctoral student, 1st cohorte

A6 - Role of quantitative and qualitative variation in gene dosage of defensin (hBD-1 to hBD-3) and the cathelicidin (VDR) in the susceptibility to pneumococcal pneumonia